(Q47912229)

6 February 2018

review article

1 reference

title

Nutritional modulation of immunity and the inflammatory response (English)

1 reference

6 February 2018

author name string

Lin E

series ordinal

1

1 reference

6 February 2018

Kotani JG

series ordinal

2

1 reference

6 February 2018

Lowry SF

series ordinal

3

1 reference

6 February 2018

publication date

1 June 1998

1 reference

6 February 2018

published in

Nutrition

1 reference

6 February 2018

volume

14

1 reference

6 February 2018

issue

6

1 reference

6 February 2018

page(s)

545-550

1 reference

6 February 2018

Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Perioperative total parenteral nutrition in surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Energy metabolism in sepsis and injury

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Biologic control of injury and inflammation: much more than too little or too late

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Production of interleukin-1-receptor antagonist during experimental endotoxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Interleukin-1 contributes to increased concentrations of soluble tumor necrosis factor receptor type I in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Transforming growth factor-beta 1 inhibits synthesis of cytokines in endotoxin-stimulated human whole blood

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Interleukin-6 delays neutrophil apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Interleukin-10 production during septicaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

The anatomical basis of intestinal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

1997 Harry M. Vars Research Award. Does the route of feeding modify gut barrier function and clinical outcome in patients after major upper gastrointestinal surgery?

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Preoperative total parenteral nutrition influences postoperative systemic cytokine responses after colorectal surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

The route of nutritional support in the critically ill: physiological and economical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Gut mucosal nutritional support--enteral nutrition as primary therapy after multiple system trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Glutamine and intestinal immune cells in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Efficacy of nutritional pharmacology in surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Effect of a fish oil structured lipid-based diet on prostaglandin release from mononuclear cells in cancer patients after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Polyadenylic-polyuridylic acid enhances the natural cell-mediated cytotoxicity in patients with breast cancer undergoing mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Early postoperative enteral immunonutrition: clinical outcome and cost-comparison analysis in surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Randomized trial of immune-enhancing enteral nutrition in burn patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

Time-scale of interleukin-6, myeloid related proteins (MRP), C reactive protein (CRP), and endotoxin plasma levels during the postoperative acute phase reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900046-X

7 January 2021

10.1016/S0899-9007(98)00046-X

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018